Dynavax Technologies Corporation (DVAX)
Feb 10, 2026 - DVAX was delisted (reason: acquired by SNY)
15.50
0.00 (0.00%)
Inactive · Last trade price on Feb 9, 2026
Dynavax Technologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 160.25 | 95.88 | 150.28 | 202 | 436.19 | 32.07 |
Short-Term Investments | 487.57 | 617.95 | 592.02 | 422.39 | 109.76 | 132.96 |
Cash & Short-Term Investments | 647.82 | 713.83 | 742.3 | 624.4 | 545.95 | 165.04 |
Cash Growth | -15.21% | -3.84% | 18.88% | 14.37% | 230.81% | 9.26% |
Accounts Receivable | 72.36 | 45.28 | 40.61 | 145.13 | 116.22 | 22.31 |
Other Receivables | 0.96 | 1.63 | 3.93 | 2.39 | 15.6 | 0.36 |
Total Trade Receivables | 73.32 | 46.91 | 44.53 | 147.52 | 131.82 | 22.66 |
Inventory | 73.29 | 70.05 | 53.29 | 59.45 | 61.34 | 63.69 |
Other Current Assets | 19.91 | 18.15 | 19 | 85.63 | 233.42 | 38.63 |
Total Current Assets | 814.33 | 848.94 | 859.12 | 916.99 | 972.52 | 290.02 |
Net Property, Plant & Equipment | 65.76 | 60.61 | 61.58 | 63.34 | 60.98 | 57.15 |
Goodwill | 2.2 | 1.95 | 2.07 | 2.01 | 2.13 | 2.3 |
Other Long-Term Assets | 64.22 | 74.76 | 74.33 | 3.52 | 3.62 | 3.81 |
Total Assets | 946.51 | 986.26 | 997.1 | 985.85 | 1,039 | 353.27 |
Accounts Payable | 3.95 | 9.06 | 5.25 | 3.21 | 2.6 | 3.31 |
Accrued Expenses | 58.59 | 65.38 | 52.43 | 143.23 | 183.33 | 21.9 |
Current Portion of Long-Term Debt | 40.07 | - | - | - | - | - |
Unearned Revenue | - | - | - | - | 349.86 | 38.21 |
Other Current Liabilities | 4.23 | 4.2 | 4.52 | 3.63 | 20.61 | 13.98 |
Total Current Liabilities | 106.84 | 78.63 | 62.2 | 150.07 | 556.4 | 77.41 |
Long-Term Debt | 220.97 | 223.85 | 222.7 | 221.58 | 220.49 | 179.81 |
Long-Term Leases | 23.99 | 26.39 | 29.72 | 32.8 | 34.32 | 34.79 |
Other Long-Term Liabilities | 60.58 | 60.58 | 60.41 | 0.38 | 5.66 | 2.57 |
Total Long-Term Liabilities | 305.53 | 310.82 | 312.83 | 254.76 | 260.47 | 217.17 |
Total Liabilities | 412.37 | 389.46 | 375.02 | 404.84 | 816.87 | 294.58 |
Common Stock | 0.12 | 0.13 | 0.13 | 0.13 | 0.12 | 0.11 |
Additional Paid-in Capital | 1,487 | 1,505 | 1,555 | 1,511 | 1,442 | 1,352 |
Accumulated Other Comprehensive Income | 0.8 | -4.72 | -2.11 | -5.44 | -2.27 | 0.27 |
Retained Earnings | -953.73 | -903.28 | -930.58 | -924.2 | -1,217 | -1,294 |
Shareholders' Equity | 534.14 | 596.8 | 622.07 | 581.01 | 222.37 | 58.69 |
Total Liabilities & Equity | 946.51 | 986.26 | 997.1 | 985.85 | 1,039 | 353.27 |
Total Debt | 285.02 | 250.24 | 252.42 | 254.38 | 254.81 | 214.6 |
Net Cash (Debt) | 362.79 | 463.59 | 489.88 | 370.02 | 291.14 | -49.56 |
Net Cash Growth | -21.74% | -5.37% | 32.40% | 27.09% | - | - |
Net Cash Per Share | 2.63 | 3.48 | 3.81 | 2.45 | 2.19 | -0.49 |
Book Value | 534.14 | 596.8 | 622.07 | 581.01 | 222.37 | 58.69 |
Book Value Per Share | 3.87 | 4.48 | 4.83 | 3.85 | 1.67 | 0.58 |
Tangible Book Value | 531.94 | 594.85 | 620.01 | 579.01 | 220.25 | 56.4 |
Tangible Book Value Per Share | 3.85 | 4.46 | 4.82 | 3.84 | 1.66 | 0.56 |